Cash-strapped Viva Biotech sells stake and plans spinoff
The biotech has gained a capital injection from Temasek and a major Chinese investor, but the deal has not boosted investor confidence Key Takeaways: As well as tapping strategic investors,…
1873.HK
Recent Articles
RELATED ARTICLES
-
XJ International gets lesson on perils of zero-coupon bonds
1765.HK
-
Xtep races to cut loose money-losing brands
1368.HK
-
GenScript losses shrink on strong growth for cancer cell therapy
1548.HK
-
Will Genscript cash out of Legend Biotech in the face of fat profit temptation?
1548.HK LEGN.US
- Lopal Tech seeks cash after losses balloon with lithium price plunge
Discover hidden China stock gems in our weekly newsletter